2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Qsymia: new trials by email Literature Review of Qsymia trials Research Report on Qsymia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FDA Approved Medication to Reduce Binge Eating and/or Purging Phentermine/Topiramate-First, Placebo - Binge Eating Disorder, Bulimia Nervosa | Phase 1 | Completed | Stanford University | 22 | 2015-10-30 | 2018-05-14 |
| A Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic Impairment Phentermine and Topiramate - Hepatic Impairment | Phase 1 | Completed | VIVUS LLC | 18 | 2008-10-01 | 2009-12-01 |
Binge-Eating Disorder (1) · Bulimia (1) · Bulimia Nervosa (1)
Stanford University (1) · VIVUS LLC (1)
United States (2)
Debra L Safer, MD (1) · Sarah Adler, PsyD (1) · Shebani Sethi, MD (1) · Shiyin Yee, PhD (1)